From: healthline.com When you learn you have breast cancer, lean on your friends, breast cancer survivors, and treatment team while you decide what’s best for you. Here’s how one woman took control of her diagnosis. It can be a big shock to find out you’ve received a breast cancer diagnosis, even if it’s in the early stages. There’s a lot …
Three out of ten breast cancers detected between screenings, study finds
By Anna Björklund, Karolinska Institutet From: medicalxpress.com In a new study, researchers from Karolinska Institutet have shown that so-called interval cancers, which are detected between two screening sessions, account for a significant proportion of breast cancer cases and that certain risk factors may increase the likelihood of developing this type of cancer. The study was published in the journal JAMA …
Study reveals progressive breast shrinkage after breast-conserving therapy
Source: Wolters Kluwer From: news-medical.net For women with early-stage breast cancer, breast-conserving therapy (BCT) including radiation therapy (RT) leads to progressive reduction in breast size over time, reports a study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer. New data on …
Aromatase Inhibitors Show Greater Benefit in Preventing Contralateral Breast Cancer
By: Alexandra Gerlach, Associate Editor From: pharmacytimes.com Key Takeaways Endocrine therapy reduces CBC risk, especially in ER+/HER2- breast cancer, with aromatase inhibitors being more effective than tamoxifen. Longer therapy durations, particularly 10-year aromatase inhibitor regimens, significantly decrease CBC cases, with younger women benefiting most. The study highlights the importance of personalized treatment plans, considering age, side effects, and adherence to …
Development of Novel HER2-Targeted Therapies Could Help Reshape Treatment for HER2+ Breast Cancer
By: Jax DiEugenio From: onclive.com Fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) and other novel antibody-drug conjugates (ADCs) currently under development have represented key change in the treatment landscape for HER2-positive breast cancer, and other novel HER2-targeted therapies could also bring further change to the space, according to Kelly E. McCann, MD, PhD. “We have to think about how can we optimize care …
Nanotechnology innovation aims to improve breast cancer treatment
Source: The University of Queensland From: news-medical.net University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer. Professor Chengzhong (Michael) Yu and his team are developing novel nanoparticles that could dramatically increase the effectiveness of immunotherapies when treating triple-negative breast cancer (TNBC). TNBC is aggressive, fast-growing and accounts for …
Crucial Answers on Long-Term Physical Health Effects From Breast Cancer Treatments
By: Tim Cortese From: cancernetwork.com Clara Bodelon, PhD, MS, senior principal scientist of survivor research at the American Cancer Society, spoke with CancerNetwork® about a study she published in JAMA Network Open that reported chemotherapy leads to more significant long-term health declines compared with endocrine therapy in the treatment of breast cancer. The study found that the greatest decline of …
I found out I have breast cancer 5 days after my mum died from the same disease – don’t make our mistakes
By; Julia Sidwell WHEN Sue Ware was planning her mum’s funeral after losing her to breast cancer, she never dreamed she would also get the disease. But that’s exactly what happened. Just five days after her mother Betty died, 59-year-old Sue, from Dunstable, Bedfordshire, was diagnosed with inflammatory breast cancer after noticing redness on her right boob. She first spotted …
Tamoxifen Shows No Notable Long-Term Physical Health Decline in BC Survivors
By: Clara Bodelon, PhD, MS From: cancernetwork.com Endocrine therapy showed more favorable results than chemotherapy concerning declining physical health after the treatment of patients with breast cancer. Of methods of endocrine therapy, however, tamoxifen showed even more favorable results than aromatase inhibitors. CancerNetwork® spoke with Clara Bodelon, PhD, MS, senior principal scientist of survivor research at the American Cancer Society …
How Breast Cancer Changed My Approach to Beauty
By: Jennifer Bringle From: bezzybc.com Hair loss, dry skin, and damaged nails are common side effects of chemo and can be difficult to manage. Making a few changes to my beauty routine helped me feel better and gave me a much-needed sense of control. When I received the news I’d been diagnosed with breast cancer and would undergo a regimen …